Signaling Pathway
Xaluritamig is a monoclonal antibody designed to target both CD3E and STEAP1. This dual specificity allows for the potential engagement of immune system modulation through CD3E interaction and direct targeting of STEAP1, a protein implicated in several oncologic processes. Xaluritamig is primarily used in research focused on cancer immunotherapy and the study of immune response mechanisms.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Xaluritamig is a monoclonal antibody designed to target both CD3E and STEAP1. This dual specificity allows for the potential engagement of immune system modulation through CD3E interaction and direct targeting of STEAP1, a protein implicated in several oncologic processes. Xaluritamig is primarily used in research focused on cancer immunotherapy and the study of immune response mechanisms. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
